At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 254 enrolled
Drug / intervention
Permethrin Cream, 5% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% (Encube Ethicals) Compared to Elimite™ Cream (Permethrin) 5% (Prestium Pharma, Inc.) in the Treatment of Scabies
In Brief
A Phase 3 clinical trial evaluating Permethrin Cream, 5% and Elimite™ Cream (permethrin) 5% for Scabies. Completed, enrolled 254 participants across 15 sites in 3 countries.
Detailed Summary
Study to Evaluate the Therapeutic Equivalence of Permethrin Cream 5%in the Treatment of Scabies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScabies
CountriesEl Salvador, Puerto Rico, United States
CollaboratorsNovum Pharmaceutical Research Services
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
Enrollment StartJun 2017
First PostedJun 2017
Primary CompletionNov 2017
TodayJul 2026
First PostedJun 7, 2017
Enrollment StartJun 1, 2017
Primary CompletionNov 11, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.1 years ago
Interventions
Permethrin Cream, 5%drug
Permethrin Cream 5%
Elimite™ Cream (permethrin) 5%drug
Permethrin Cream 5%